NCCN Funds Research to Address Side Effects of PARP Inhibitors in Prostate Cancer Treatment
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has announced funding for a new project aimed at improving the management of side effects caused …
NCCN Funds Research to Address Side Effects of PARP Inhibitors in Prostate Cancer Treatment Read More